Blogs
ERP
CATEGORIES
ERP
Pharma & Life Sciences
September 04, 2026
Surfing the AI Wave: How Pharma can Harness Agents in ERP
The Fastest Tech Wave Ever Technology adoption has never moved this fast. Mobile phones took 16 years to reach 100 million users. The Internet needed seven....
Thomas Van Dorpe
ERP
Pharma & Life Sciences
September 02, 2026
Launching a Medical Device in the US? Start With These Four Steps
Being ISO 13485 certified doesn't automatically make you FDA-inspection-ready. It gets you close, but the two frameworks are not a one-to-one match, and the...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
September 02, 2026
EU GMP Annex 11 & Annex 22: The New Compliance Reality for AI in Pharma
Pharma is in the middle of its biggest regulatory shift in more than 30 years. For the first time, regulators are explicitly addressing AI, with dedicated...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
September 02, 2026
AI in medical devices: What the FDA's predetermined change control plan actually covers
Your medical device's AI algorithm will not stay the same after it reaches the market. It will be retrained, refined, and improved, and every one of those...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
August 26, 2026
Why your CE mark won't get you onto the US Market
For many European medical device companies, the US represents the next growth market. The surprise comes when they discover thata CE mark, established quality...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
June 10, 2026
What Pharma Can (and Cannot) Do with AI Under Annex 22
The business wants AI agents. The use cases look compelling. The technology is evolving faster than most organisations can comfortably track. Then someone from...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
May 27, 2026
Who Owns AI in Pharma? Why Governance Must Be Cross‑Functional
Most pharma AI initiatives do not fail because the technology does not work. They fail because no one can clearly answer a much more basic question: Who owns...
Thomas Van Dorpe
ERP
Pharma & Life Sciences
April 09, 2026
Why AI belongs on the Pharma C-level strategic agenda
Artificial intelligence is no longer a future technology for pharma; it is already part of the infrastructure that supports scientific progress, operational...
Thomas Nielsen
ERP
Agentic AI
April 07, 2026
From Model Power to Business Impact: Key Takeaways from AI & Copilot Summit 2026
Model performance is no longer the primary bottleneck to AI adoption. The real challenge is connecting it to your business context and systems. The AI and...
Thomas Van Dorpe
ERP
Finance & Operations
January 25, 2026
Navigating a complex ERP landscape: expert selection advice
Are you facing the choice of a new ERP system? Competition in the ERP market remains fierce, and every platform promises the ultimate solution. A wrong move...
Thomas Van Dorpe